Skip to content

Clinical Evaluation of Finger Acupoint Pressure at Neiguan and Daling Combined with Standardized Instruction to Improve Chest Pain Symptoms in Patients with Acute Coronary Syndrome

Clinical Evaluation of Finger Acupoint Pressure at Neiguan and Daling Combined with Standardized Instruction to Improve Chest Pain Symptoms in Patients with Acute Coronary Syndrome

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600116013
Enrollment
Unknown
Registered
2026-01-04
Start date
2024-09-24
Completion date
Unknown
Last updated
2026-01-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Coronary Syndrome (ACS)

Interventions

Intervention group:Finger acupoint pressure at Neiguan (PC6) and Daling (PC7) for 6–10 minutes, applied bilaterally to elicit deqi sensations such as soreness, numbness, or distension. Standardized in

Sponsors

The Third Affiliated Hospital of Zhejiang Chinese Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
30 Years to 85 Years

Inclusion criteria

Inclusion criteria: 1. Diagnosed with acute coronary syndrome according to the 2019 ACS emergency diagnostic guideline. 2. Acute onset of chest pain or chest tightness, with or without ST-segment changes. 3. Able to provide informed consent after stabilization. 4. Age 30–85 years, conscious, and able to communicate clearly.

Exclusion criteria

Exclusion criteria: 1. Heart failure, respiratory failure, renal failure, or other severe systemic diseases. 2. History of neurological or psychiatric disorders, or severe cognitive impairment. 3. Inability to communicate (aphasia, severe dementia, coma, profound hearing impairment). 4. Pregnant women. 5. Poor compliance or inability to cooperate. 6. Participation in other clinical trials that may affect results. 7. Any of the above conditions leads to exclusion.

Design outcomes

Primary

MeasureTime frame
Chest pain score (NRS + Facial Rating Scale);

Secondary

MeasureTime frame
Chest tightness score (0–10 scale);Anxiety score (SAS)&Fear of progression score (FoP-Q);Number of nausea episodes&vomiting episodes;ECG;Cardiac biomarkers (troponin / CK-MB);

Countries

China

Contacts

Public ContactXing Tang

The Third Affiliated Hospital of Zhejiang Chinese Medical University

txokw@126.com+86 189 5807 7883

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026